Literature DB >> 5523730

Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.

F Kradolfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5523730     DOI： 10.1159/000386838

Source DB:  PubMed          Journal:  Antibiot Chemother


× No keyword cloud information.
  3 in total

1.  In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.

Authors:  T Yamamoto; R Amitani; K Suzuki; E Tanaka; T Murayama; F Kuze
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

2.  In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.

Authors:  D R Ashtekar; R Costa-Perira; K Nagrajan; N Vishvanathan; A D Bhatt; W Rittel
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

3.  Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.

Authors:  Meredith Milstein; Leonid Lecca; Charles Peloquin; Denis Mitchison; Kwonjune Seung; Marcello Pagano; David Coleman; Elna Osso; Julia Coit; Dante Elmo Vargas Vasquez; Epifanio Sanchez Garavito; Roger Calderon; Carmen Contreras; Geraint Davies; Carole D Mitnick
Journal:  BMC Infect Dis       Date:  2016-08-27       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.